EMEA (Europe, Middle East and Africa) Human Immune Globulin Intravenous Market Report 2018

March 2018 | 118 pages | ID: E5C27A3E8E8EN
QYResearch

Abstracts

In this report, the EMEA Human Immune Globulin Intravenous market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Human Immune Globulin Intravenous for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Immune Globulin Intravenous market competition by top manufacturers/players, with Human Immune Globulin Intravenous sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Baxter
• Grifols
• CSL
• Octapharma
• Biotest
• Kedrion
• Hualan Bio
• CNBG
• Shanghai RAAS
• CBPO
• LFB Group
• BPL
• Sichuan Yuanda Shuyang

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• IVIg Liquid
• IVIg Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Immunodeficiency
• Autoimmune Disease
• Acute Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Immune Globulin Intravenous Market Report 2018

1 HUMAN IMMUNE GLOBULIN INTRAVENOUS OVERVIEW

1.1 Product Overview and Scope of Human Immune Globulin Intravenous
1.2 Classification of Human Immune Globulin Intravenous
  1.2.1 EMEA Human Immune Globulin Intravenous Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Human Immune Globulin Intravenous Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 IVIg Liquid
  1.2.4 IVIg Powder
1.3 EMEA Human Immune Globulin Intravenous Market by Application/End Users
  1.3.1 EMEA Human Immune Globulin Intravenous Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Immunodeficiency
  1.3.3 Autoimmune Disease
  1.3.4 Acute Infection
1.4 EMEA Human Immune Globulin Intravenous Market by Region
  1.4.1 EMEA Human Immune Globulin Intravenous Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Human Immune Globulin Intravenous (2013-2025)
  1.5.1 EMEA Human Immune Globulin Intravenous Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2025)

2 EMEA HUMAN IMMUNE GLOBULIN INTRAVENOUS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Immune Globulin Intravenous Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Immune Globulin Intravenous Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Human Immune Globulin Intravenous Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Human Immune Globulin Intravenous Sale Price by Players (2013-2018)
2.2 EMEA Human Immune Globulin Intravenous (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Immune Globulin Intravenous Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Human Immune Globulin Intravenous Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Human Immune Globulin Intravenous Sale Price by Type (2013-2018)
2.3 EMEA Human Immune Globulin Intravenous (Volume) by Application
2.4 EMEA Human Immune Globulin Intravenous (Volume and Value) by Region
  2.4.1 EMEA Human Immune Globulin Intravenous Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Human Immune Globulin Intravenous Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Human Immune Globulin Intravenous Sales Price by Region (2013-2018)

3 EUROPE HUMAN IMMUNE GLOBULIN INTRAVENOUS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Immune Globulin Intravenous Sales and Value (2013-2018)
  3.1.1 Europe Human Immune Globulin Intravenous Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2018)
3.2 Europe Human Immune Globulin Intravenous Sales and Market Share by Type
3.3 Europe Human Immune Globulin Intravenous Sales and Market Share by Application
3.4 Europe Human Immune Globulin Intravenous Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Immune Globulin Intravenous Sales Volume by Countries (2013-2018)
  3.4.2 Europe Human Immune Globulin Intravenous Revenue by Countries (2013-2018)
  3.4.3 Germany Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  3.4.4 France Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  3.4.5 UK Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  3.4.6 Russia Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  3.4.7 Italy Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)

4 MIDDLE EAST HUMAN IMMUNE GLOBULIN INTRAVENOUS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Immune Globulin Intravenous Sales and Value (2013-2018)
  4.1.1 Middle East Human Immune Globulin Intravenous Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2018)
4.2 Middle East Human Immune Globulin Intravenous Sales and Market Share by Type
4.3 Middle East Human Immune Globulin Intravenous Sales and Market Share by Application
4.4 Middle East Human Immune Globulin Intravenous Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Immune Globulin Intravenous Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Human Immune Globulin Intravenous Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  4.4.4 Israel Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  4.4.5 UAE Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  4.4.6 Iran Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)

5 AFRICA HUMAN IMMUNE GLOBULIN INTRAVENOUS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Immune Globulin Intravenous Sales and Value (2013-2018)
  5.1.1 Africa Human Immune Globulin Intravenous Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2018)
5.2 Africa Human Immune Globulin Intravenous Sales and Market Share by Type
5.3 Africa Human Immune Globulin Intravenous Sales and Market Share by Application
5.4 Africa Human Immune Globulin Intravenous Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Immune Globulin Intravenous Sales Volume by Countries (2013-2018)
  5.4.2 Africa Human Immune Globulin Intravenous Revenue by Countries (2013-2018)
  5.4.3 South Africa Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Human Immune Globulin Intravenous Sales and Growth Rate (2013-2018)

6 EMEA HUMAN IMMUNE GLOBULIN INTRAVENOUS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Baxter
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Baxter Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Grifols
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Octapharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biotest
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Hualan Bio
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 CNBG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Shanghai RAAS
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 CBPO
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Human Immune Globulin Intravenous Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 LFB Group
6.12 BPL
6.13 Sichuan Yuanda Shuyang

7 HUMAN IMMUNE GLOBULIN INTRAVENOUS MANUFACTURING COST ANALYSIS

7.1 Human Immune Globulin Intravenous Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Immune Globulin Intravenous

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Immune Globulin Intravenous Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Immune Globulin Intravenous Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET FORECAST (2018-2025)

11.1 EMEA Human Immune Globulin Intravenous Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Human Immune Globulin Intravenous Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Human Immune Globulin Intravenous Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Human Immune Globulin Intravenous Price and Trend Forecast (2018-2025)
11.2 EMEA Human Immune Globulin Intravenous Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Human Immune Globulin Intravenous Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Human Immune Globulin Intravenous Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Human Immune Globulin Intravenous Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Human Immune Globulin Intravenous Sales Forecast by Type (2018-2025)
11.7 EMEA Human Immune Globulin Intravenous Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Immune Globulin Intravenous
Figure EMEA Human Immune Globulin Intravenous Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Human Immune Globulin Intravenous Sales Volume Market Share by Type (Product Category) in 2017
Figure IVIg Liquid Product Picture
Figure IVIg Powder Product Picture
Figure EMEA Human Immune Globulin Intravenous Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Human Immune Globulin Intravenous by Application in 2017
Figure Immunodeficiency Examples
Table Key Downstream Customer in Immunodeficiency
Figure Autoimmune Disease Examples
Table Key Downstream Customer in Autoimmune Disease
Figure Acute Infection Examples
Table Key Downstream Customer in Acute Infection
Figure EMEA Human Immune Globulin Intravenous Market Size (Million USD) by Region (2013-2025)
Figure Europe Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Human Immune Globulin Intravenous Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Human Immune Globulin Intravenous Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Human Immune Globulin Intravenous Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Immune Globulin Intravenous Sales Volume and Growth Rate (2013-2025)
Figure EMEA Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Human Immune Globulin Intravenous Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales Share by Players (2013-2018)
Figure 2017 Human Immune Globulin Intravenous Sales Share by Players
Figure 2017 Human Immune Globulin Intravenous Sales Share by Players
Figure EMEA Human Immune Globulin Intravenous Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Human Immune Globulin Intravenous Revenue (Million USD) by Players (2013-2018)
Table EMEA Human Immune Globulin Intravenous Revenue Share by Players (2013-2018)
Table 2017 EMEA Human Immune Globulin Intravenous Revenue Share by Players
Table 2017 EMEA Human Immune Globulin Intravenous Revenue Share by Players
Table EMEA Human Immune Globulin Intravenous Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales Share by Type (2013-2018)
Figure Sales Market Share of Human Immune Globulin Intravenous by Type (2013-2018)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share by Type (2013-2018)
Table EMEA Human Immune Globulin Intravenous Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Human Immune Globulin Intravenous Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Immune Globulin Intravenous by Type in 2017
Table EMEA Human Immune Globulin Intravenous Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales Share by Application (2013-2018)
Figure Sales Market Share of Human Immune Globulin Intravenous by Application (2013-2018)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share by Application in 2017
Table EMEA Human Immune Globulin Intravenous Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Human Immune Globulin Intravenous Sales Share by Region (2013-2018)
Figure Sales Market Share of Human Immune Globulin Intravenous by Region (2013-2018)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share in 2017
Table EMEA Human Immune Globulin Intravenous Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Human Immune Globulin Intravenous Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Human Immune Globulin Intravenous by Region (2013-2018)
Figure EMEA Human Immune Globulin Intravenous Revenue Market Share Regions in 2017
Table EMEA Human Immune Globulin Intravenous Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Human Immune Globulin Intravenous Revenue and Growth Rate (2013-2018)
Table Europe Human Immune Globulin Intravenous Sales (K Units) by Type (2013-2018)
Table Europe Human Immune Globulin Intravenous Market Share by Type (2013-2018)
Figure Europe Human Immune Globulin Intravenous Market Share by Type in 2017
Table Europe Human Immune Globulin Intravenous Sales (K Units) by Application (2013-2018)
Table Europe Human Immune Globulin Intravenous Market Share by Application (2013-2018)
Figure Europe Human Immune Globulin Intravenous Market Share by Application in 2017
Table Europe Human Immune Globulin Intravenous Sales (K Units) by Countries (2013-2018)
Table Europe Human Immune Globulin Intravenous Sales Market Share by Countries (2013-2018)
Figure Europe Human Immune Globulin Intravenous Sales Market Share by Countries (2013-2018)
Figure Europe Human Immune Globulin Intravenous Sales Market Share by Countries in 2017
Table Europe Human Immune Globulin Intravenous Revenue (Million USD) by Countries (2013-2018)
Table Europe Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Europe Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Europe Human Immune Globulin Intravenous Revenue Market Share by Countries in 2017
Figure Germany Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure France Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure UK Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Human Immune Globulin Intravenous Sales (K Units) by Type (2013-2018)
Table Middle East Human Immune Globulin Intravenous Market Share by Type (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Market Share by Type (2013-2018)
Table Middle East Human Immune Globulin Intravenous Sales (K Units) by Applications (2013-2018)
Table Middle East Human Immune Globulin Intravenous Market Share by Applications (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Sales Market Share by Application in 2017
Table Middle East Human Immune Globulin Intravenous Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Human Immune Globulin Intravenous Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Sales Volume Market Share by Countries in 2017
Table Middle East Human Immune Globulin Intravenous Revenue (Million USD) by Countries (2013-2018)
Table Middle East Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Immune Globulin Intravenous Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Human Immune Globulin Intravenous Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Human Immune Globulin Intravenous Sales (K Units) by Type (2013-2018)
Table Africa Human Immune Globulin Intravenous Sales Market Share by Type (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales Market Share by Type (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales Market Share by Type in 2017
Table Africa Human Immune Globulin Intravenous Sales (K Units) by Application (2013-2018)
Table Africa Human Immune Globulin Intravenous Sales Market Share by Application (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales Market Share by Application (2013-2018)
Table Africa Human Immune Globulin Intravenous Sales Volume (K Units) by Countries (2013-2018)
Table Africa Human Immune Globulin Intravenous Sales Market Share by Countries (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales Market Share by Countries (2013-2018)
Figure Africa Human Immune Globulin Intravenous Sales Market Share by Countries in 2017
Table Africa Human Immune Globulin Intravenous Revenue (Million USD) by Countries (2013-2018)
Table Africa Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Africa Human Immune Globulin Intravenous Revenue Market Share by Countries (2013-2018)
Figure Africa Human Immune Globulin Intravenous Revenue Market Share by Countries in 2017
Figure South Africa Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Table Baxter Human Immune Globulin Intravenous Basic Information List
Table Baxter Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Baxter Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Grifols Human Immune Globulin Intravenous Basic Information List
Table Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Grifols Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table CSL Human Immune Globulin Intravenous Basic Information List
Table CSL Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure CSL Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure CSL Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Octapharma Human Immune Globulin Intravenous Basic Information List
Table Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Octapharma Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Biotest Human Immune Globulin Intravenous Basic Information List
Table Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Biotest Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Kedrion Human Immune Globulin Intravenous Basic Information List
Table Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Kedrion Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Hualan Bio Human Immune Globulin Intravenous Basic Information List
Table Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Hualan Bio Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table CNBG Human Immune Globulin Intravenous Basic Information List
Table CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure CNBG Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table Shanghai RAAS Human Immune Globulin Intravenous Basic Information List
Table Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure Shanghai RAAS Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table CBPO Human Immune Globulin Intravenous Basic Information List
Table CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Sales (K Units) and Growth Rate (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Sales Market Share in EMEA (2013-2018)
Figure CBPO Human Immune Globulin Intravenous Revenue Market Share in EMEA (2013-2018)
Table LFB Group Human Immune Globulin Intravenous Basic Information List
Table BPL Human Immune Globulin Intravenous Basic Information List
Table Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Immune Globulin Intravenous
Figure Manufacturing Process Analysis of Human Immune Globulin Intravenous
Figure Human Immune Globulin Intravenous Industrial Chain Analysis
Table Raw Materials Sources of Human Immune Globulin Intravenous Major Manufacturers in 2017
Table Major Buyers of Human Immune Globulin Intravenous
Table Distributors/Traders List
Figure EMEA Human Immune Globulin Intravenous Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Human Immune Globulin Intravenous Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share Forecast by Region (2018-2025)
Table EMEA Human Immune Globulin Intravenous Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Revenue Market Share Forecast by Region (2018-2025)
Table Europe Human Immune Globulin Intravenous Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Human Immune Globulin Intravenous Sales Market Share Forecast by Countries (2018-2025)
Table Europe Human Immune Globulin Intravenous Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Human Immune Globulin Intravenous Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Human Immune Globulin Intravenous Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Human Immune Globulin Intravenous Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Human Immune Globulin Intravenous Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Human Immune Globulin Intravenous Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Human Immune Globulin Intravenous Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Human Immune Globulin Intravenous Sales Market Share Forecast by Countries (2018-2025)
Table Africa Human Immune Globulin Intravenous Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Human Immune Globulin Intravenous Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Human Immune Globulin Intravenous Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2018-2025)
Table EMEA Human Immune Globulin Intravenous Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Human Immune Globulin Intravenous Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources